Nucleic Acid Ligands With Protein-like Side Chains: Modified Aptamers and Their Use as Diagnostic and Therapeutic Agents - Wikidata - wikimedia - TriplyDB

Nucleic Acid Ligands With Protein-like Side Chains: Modified Aptamers and Their Use as Diagnostic and Therapeutic Agents

Nucleic Acid Ligands With Protein-like Side Chains: Modified Aptamers and Their Use as Diagnostic and Therapeutic Agents

http://www.wikidata.org/entity/Q35309726

about

Aptamers: A Feasible Technology in Cancer Immunotherapy Small-Molecule Binding Aptamers: Selection Strategies, Characterization, and Applications.Modified Nucleoside Triphosphates for In-vitro Selection Techniques Expected and unexpected features of protein-binding RNA aptamers From selection hits to clinical leads: progress in aptamer discovery Generation of Aptamers with an Expanded Chemical Repertoire Aptamer Microarrays-Current Status and Future Prospects Fit for the Eye: Aptamers in Ocular Disorders Structural computational modeling of RNA aptamers Emerging Affinity-Based Proteomic Technologies for Large-Scale Plasma Profiling in Cardiovascular Disease.In vitro Selection and Interaction Studies of a DNA Aptamer Targeting Protein A.Large-scale serum protein biomarker discovery in Duchenne muscular dystrophy RAID3--An interleukin-6 receptor-binding aptamer with post-selective modification-resistant affinity The Toolbox for Modified Aptamers.Respiratory Mucosal Proteome Quantification in Human Influenza Infections Library-based display technologies: where do we stand?Six-SOMAmer Index Relating to Immune, Protease and Angiogenic Functions Predicts Progression in IPF.Enzymatic Synthesis of Sequence-Defined Synthetic Nucleic Acid Polymers with Diverse Functional Groups.In vitro evolution of chemically-modified nucleic acid aptamers: Pros and cons, and comprehensive selection strategies Evolution of Complex Target SELEX to Identify Aptamers against Mammalian Cell-Surface Antigens DNA display of folded RNA libraries enabling RNA-SELEX without reverse transcription.DNA-Catalyzed Amide Hydrolysis Oligonucleotide aptamers: A next-generation technology for the capture and detection of circulating tumor cells.Identification of definitive serum biomarkers associated with disease activity in primary Sjögren's syndrome Proteomics analysis of vesicles isolated from plasma and urine of prostate cancer patients using a multiplex, aptamer-based protein array.The Relationship of Novel Plasma Proteins in the Early Neonatal Period With Retinopathy of Prematurity.The relationship of circulating proteins in early pregnancy with preterm birth.Highly Multiplexed Proteomic Analysis of Quantiferon Supernatants To Identify Biomarkers of Latent Tuberculosis Infection.Selection of DNA aptamers with two modified bases.Next-Generation Nucleic Acid Aptamers with Two-Base-Modified Nucleotides Have Improved Binding Affinity and Potency.A review on electronic bio-sensing approaches based on non-antibody recognition elements.Analysis of ATP and AMP binding to a DNA aptamer and its imidazole-tethered derivatives by surface plasmon resonance.Trends in aptamer selection methods and applications.An immune clock of human pregnancy.2-Methoxypyridine as Thymidine Mimic in Watson-Crick Base Pairs of DNA and PNA: Synthesis, Thermal Stability and NMR Structural Studies.The expanding world of DNA and RNA.Aptamers as Therapeutics.Potential of High-Affinity, Slow Off-Rate Modified Aptamer (SOMAmer) Reagents for Mycobacterium tuberculosis Proteins as Tools for Infection Models and Diagnostic Applications.Real-time label-free quantitative fluorescence microscopy-based detection of ATP using a tunable fluorescent nano-aptasensor platform.Influence of 5-N-carboxamide modifications on the thermodynamic stability of oligonucleotides.

P2860

Q26740303-CDB9ACB9-EB54-47BE-8669-BCD8C42DF8E6 Q26744499-4F42C2E5-ED58-4CD5-A33A-3DA077B14ECE Q26747256-D0F776D3-BEEA-4AEF-8FF6-C2910A0F00C4 Q26750235-3FD62B49-68AD-4B2F-B825-045302040AE5 Q26752799-0026B246-DA15-4736-884B-0099A7A9D513 Q26782794-8266600A-CCD6-4CCF-A9AD-91BC5E3E23EE Q28083114-AF95D34E-DC3B-49E5-8C49-00BBE60AC04F Q28828283-42469B69-8A3A-4B78-8C46-91A38430D06E Q28828891-3C0F1ECC-9B64-4394-950E-F78AAD82EF69 Q30234679-926F4427-D33D-4C5F-9417-D650D4AB1B7A Q30406029-68BC330E-0F20-4BFC-86E0-7ECD6E91616F Q35740280-2E8A4609-61B4-4EF5-BCA8-28DC47EC573D Q35780423-4FC936A2-205B-4B0F-BA62-2B958AF5B239 Q35852997-F3977CDC-1362-42F4-B8D9-E5FB7E05CCC2 Q35992338-8200819A-2418-4BD7-B3DB-52ED14AE938F Q36053596-64FF9A0C-A51D-4B67-B913-1E83AF274E67 Q36095068-1A1D32AA-391C-44C6-B881-371AE78F0294 Q36135048-9D0230FB-48F5-4DBF-9334-77B68AB7395C Q36156320-CD5BABD0-5846-4B3A-8DDA-F9467CC3B384 Q36266158-F40D79BF-73A1-4005-A95C-8AD5F2E0F336 Q36285843-C688FBA6-F49B-4657-A1CC-A12562AE8931 Q36619856-C323AC20-9CA0-48D1-865B-15ECECF7DBE4 Q36689755-064B9305-3E79-4E9C-8259-FDE61306A27C Q36903959-9DD1F9CD-D927-4968-AB94-30E6950B65B6 Q37057070-8F0D567F-2898-4F6C-99E5-94403D1D6C44 Q37316157-7F734546-3CBB-4CAD-BDE7-937718CFBFFC Q37486145-8F7ED112-8FAD-4782-BE7A-10D38B7A67B4 Q37611851-AB704705-4EE4-48BA-A237-AEC74F57EA5C Q37711632-F64CBF67-52E8-4C3D-8D1F-2237B720E935 Q38288058-5C754EC3-049F-4168-9ABD-88CAEA3A1315 Q38293110-7160D850-890C-4310-98FF-DEF6B97FD8B7 Q38297362-AA3B41F6-A837-409E-991D-007E4928593E Q38298067-05C79EB6-7B0A-4A00-B0B5-0038F226CADE Q38597262-A9542CB1-428A-4668-87F6-FB508F8FE9CA Q38635005-3343BFA1-B2A7-4926-9D55-C9C22DA9F81D Q38938145-61A83AF2-E1C7-4562-BFA1-E74A30F5320E Q39070782-E567E58D-9543-45D2-BF37-2B102190E040 Q40099709-BE2BD3D9-D29E-4DE6-B88A-4A4F1C78C922 Q40338997-10E337D6-ECA7-4E6F-85F2-B83A7CC86F93 Q40464660-AAA21D8D-8676-4400-9EC5-FD1F6F81800C

P2860

Nucleic Acid Ligands With Protein-like Side Chains: Modified Aptamers and Their Use as Diagnostic and Therapeutic Agents

http://www.wikidata.org/entity/Q35309726

description

2014 nî lūn-bûn

@nan

2014 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Nucleic Acid Ligands With Prot ...... gnostic and Therapeutic Agents

@ast

Nucleic Acid Ligands With Prot ...... gnostic and Therapeutic Agents

@en

type

label

Nucleic Acid Ligands With Prot ...... gnostic and Therapeutic Agents

@ast

Nucleic Acid Ligands With Prot ...... gnostic and Therapeutic Agents

@en

prefLabel

Nucleic Acid Ligands With Prot ...... gnostic and Therapeutic Agents

@ast

Nucleic Acid Ligands With Prot ...... gnostic and Therapeutic Agents

@en

P1433

Q35309726-6BA29BCD-1691-46A4-8F04-52B6B13D966F

P1476

Q35309726-97101212-051E-4EEB-B7E4-DDB35DA7E821

P2093

Q35309726-2D7290EC-6E39-4162-9625-4FE89DAD4363

Q35309726-47219B11-9C86-4CED-9D35-288FC1C49D43

Q35309726-75B5270F-0DCC-4CAE-A113-E8EBE1366411

Q35309726-7E079E88-4329-47B7-B2D1-D91AB315131F

Q35309726-9B43E2B8-3FC8-4A90-B1D8-E642019B6771

Q35309726-B8A4BD48-C062-4308-8915-ED10442D350D

Q35309726-B8D2C50F-BC6E-4093-8E5D-9DDC88FA1B7E

P2860

Q35309726-0362EE44-95F4-45F4-9293-B095895BB93B

Q35309726-069E5812-598D-4486-8DCB-835AFD387053

Q35309726-07621B2A-B733-4B08-9BD5-C4CCF61445BB

Q35309726-09976A6F-0F0E-48E5-8886-708F70A58C12

Q35309726-0ABC728E-7CF7-4F8C-8460-043A44FE0D31

Q35309726-0D9D86BD-0071-4A82-9B36-6E9F8E4A1B58

Q35309726-0F4AE143-1313-4F00-A584-1C4E2008CEC5

Q35309726-10D49990-156E-4095-9172-8F2181D985E8

Q35309726-10ECF686-3ACF-4816-B175-02174A5A19B1

Q35309726-11F3F8FA-AAC3-4DDE-A97D-B058FC22A930

P304

Q35309726-320DBF86-2419-4190-804A-6189BD1FF045

P31

Q35309726-B91567A9-0C02-439E-951E-6D0FD8EB44B5

P356

Q35309726-E4B97992-9FB5-406D-BBDC-4B0860E7E954

P478

Q35309726-75D79A75-D41D-4A80-8A6A-628DC23399F4

P577

Q35309726-83D7AA0D-AEE1-4D1D-967A-15BA2A0683C0

P5875

Q35309726-E67FE86A-49F3-4151-BED4-32DAC713D7C9

P698

Q35309726-75138C10-D145-4EB0-891A-C98CCA5718F2

P932

Q35309726-008DCCA5-C127-43BA-9841-3FAB22E4B99A

P356

P1433

Molecular therapy. Nucleic acids

P1476

Nucleic Acid Ligands With Prot ...... gnostic and Therapeutic Agents

@en

P2093

Amy D Gelinas

http://www.w3.org/2001/XMLSchema#string

Daniel J Schneider

http://www.w3.org/2001/XMLSchema#string

John C Rohloff

http://www.w3.org/2001/XMLSchema#string

Larry Gold

http://www.w3.org/2001/XMLSchema#string

Nebojsa Janjic

http://www.w3.org/2001/XMLSchema#string

Thale C Jarvis

http://www.w3.org/2001/XMLSchema#string

Urs A Ochsner

http://www.w3.org/2001/XMLSchema#string

P2860

Generation of high-affinity DNA aptamers using an expanded genetic alphabet

Geometric nomenclature and classification of RNA base pairs

From oligonucleotide shapes to genomic SELEX: novel biological regulatory loops

The maximal affinity of ligands

Continuous cultures of fused cells secreting antibody of predefined specificity

The REG1 anticoagulation system: a novel actively controlled factor IX inhibitor using RNA aptamer technology for treatment of acute coronary syndrome

The structural basis for molecular recognition by the vitamin B 12 RNA aptamer

Structure determination and binding kinetics of a DNA aptamer-argininamide complex

Tertiary core rearrangements in a tight binding transfer RNA aptamer

Encapsulating streptomycin within a small 40-mer RNA

P304

e201

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/MTNA.2014.49

http://www.w3.org/2001/XMLSchema#string

P478

3

http://www.w3.org/2001/XMLSchema#string

P577

2014-10-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

266625943

http://www.w3.org/2001/XMLSchema#string

P698

25291143

http://www.w3.org/2001/XMLSchema#string

P932

4217074

http://www.w3.org/2001/XMLSchema#string